News

Titan Biotech Limited will hold its Thirty-Fourth Annual General Meeting on September 29, 2026, at 3:00 p.m. (IST) via video conferencing, with the Register of Members closed from September 23, 2026, to September 29, 2026, and a record date set for September 22, 2026, to determine eligibility for the final dividend for the financial year ended March 31, 2026. E-voting will be available from September 26, 2026, at 10:00 a.m. (IST) to September 28, 2026, at 5:00 p.m. (IST), with September 22, 2026, as the cut-off date.

Titan Biotech Limited announced several key decisions following a board meeting, informing the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE). The company will issue bonus shares in a ratio of 1:4, requiring Rs 2,06,59,250 and with an estimated credit/dispatch date of November 3, 2026. Simultaneously, the authorized share capital will increase from Rs 10,00,00,000 to Rs 10,40,00,000, expanding the company’s capacity to issue shares. Additionally, the board re-appointed Mr. Rohit Jain as an Independent Director for a five-year term, from September 30, 2026, to September 29, 2031. Mr. Jain, a Partner at Singhania & Co. LLP, brings extensive legal and corporate experience to the role.

Titan Biotech Limited has fixed September 22, 2026, as the record date for determining entitlement of members to a final dividend of Rs 0.50 per equity share of Rs 2 each for the financial year ended March 31, 2026, following a recommendation by the board of directors on May 30, 2026.

Titan Biotech Limited will seek shareholder approval for a bonus share issue at a board meeting scheduled for Thursday, September 3, 2026, according to a regulatory filing with the BSE Ltd. on August 31, 2026. The company has also closed its trading window for designated persons from August 31, 2026, and it will remain closed for 48 hours after the outcome of the board meeting is declared.

Titan Biotech Limited will close its trading window for all designated persons, their immediate relatives, and connected persons from August 31, 2026, until 48 hours after the conclusion of a board meeting scheduled for September 3, 2026, to consider a proposal for the issue of bonus shares, according to a filing with the BSE Limited.